Inventor · disambiguated record
Norman R. Rosenthal
Also filed as: ROSENTHAL NORMAN R
1 granted patent·5 pending applications·1 citations·filing 2016–2020
18Inventor score
Files withJANSSEN PHARMACEUTICA NV6
Top patents by PatentIndex Score
6 records- 0178US11207337B2Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disordersJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Dec 28, 2021·1 cites·10 claims
- 0252US2019142855A1Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disordersJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 0351US2018353470A1Methods for reducing or preventing cardiovascular events in patients with type ii diabetes mellitusJANSSEN PHARMACEUTICA NV·Filed 2018·Application pending·0 cites
- 0450US2021000792A1Methods for reducing or preventing cardiovascular events in patients with type ii diabetes mellitusJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 0545US2017071970A1Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disordersJANSSEN PHARMACEUTICA NV·Filed 2016·Application pending·0 cites
- 0634US2022160739A1Methods for treating subjects with chronic kidney diseaseJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →